✦ LIBER ✦

Anemia Management in CKD Patients in the Era of New US Food and Drug Administration Recommendations on the Use of Erythropoiesis-Stimulating Agents

✍ Scribed by Kaufman, James S.

Book ID: 122946428
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 157 KB
Volume: 61
Category: Article
ISSN: 0272-6386
DOI: 10.1053/j.ajkd.2012.12.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Update on the use of erythropoiesis-stim

Update on the use of erythropoiesis-stimulating agents (ESAs) for the management of anemia of multiple myeloma and lymphoma

✍ Eirini Katodritou; Meletios A. Dimopoulos; Konstantinos Zervas; Evangelos Terpos 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Treatment of chemotherapy-induced anemia

Treatment of chemotherapy-induced anemia in patients with ovarian cancer: Does the use of erythropoiesis-stimulating agents worsen survival?

✍ R. Rocconi; B. Long; P. Sullivan; M. Blaize; J. Brown; J. Arbuckle; K. Bevis; J. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 86 KB

New Era in Drug Interaction Evaluation:

New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process

✍ Huang, Shiew-Mei; Strong, John M.; Zhang, Lei; Reynolds, Kellie S.; Nallani, Sri 📂 Article 📅 2008 🏛 Sage Publications 🌐 English ⚖ 90 KB

Use of Erythropoiesis-Stimulating Agents

Use of Erythropoiesis-Stimulating Agents in Patients With Anemia of Chronic Kidney Disease: Overcoming the Pharmacological and Pharmacoeconomic Limitations of Existing Therapies

✍ Wish, Jay B.; Coyne, Daniel W. 📂 Article 📅 2007 🏛 Mayo Clinic 🌐 English ⚖ 136 KB

Budget impact analysis on erythropoiesis

Budget impact analysis on erythropoiesis–stimulating agents use for the management of chemotherapy-induced anaemia in Greece

✍ Eleftheria Nikolaidi, Magdalini Hatzikou… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 179 KB

Expression and function of erythropoieti

Expression and function of erythropoietin receptors in tumors : Implications for the use of erythropoiesis-stimulating agents in cancer patients

✍ Angus M. Sinclair; Marque D. Todd; Kevin Forsythe; Susan J. Knox; Steve Elliott; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB

## Abstract Safety concerns surrounding the use of recombinant human erythropoietin (Epo) to treat anemia in cancer patients were raised after 2 recent clinical studies reported a worse survival outcome in patients who received epoetin α or epoetin β compared with patients who received placebo. Alt